University of Virginia: Diabetes Mellitus, Type 2 trials

The registry lists 13 Diabetes Mellitus, Type 2 studies with University of Virginia as lead sponsor. 1 are open to participants now and 2 have results posted.

Early Phase 1 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Go Girls! Fitness Support Group Intervention Effectiveness StudyRecruitingNCT02117063Not applicable
• The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.CompletedNCT06111508Not applicableResults posted
• Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD).CompletedNCT04094064Not applicableResults posted
• Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 DiabetesCompletedNCT06024928Not applicable
• Telehealth and Meal Replacement Pilot Program for Patients With DiabetesCompletedNCT04885621
• The Use of Libre to Improve Metabolic Control and Reduce Reliance on MedicationCompletedNCT04632849Not applicable
• Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 DiabetesStatus unknownNCT04203927Early Phase 1
• Use of Closed Loop Insulin Delivery for Glucose Control in Patients With Insulin Dependent Diabetes Mellitus After Kidney TransplantationWithdrawnNCT04189510Not applicable
• Benefits of Continuous Glucose Monitoring With GEM Lifestyle Modification for Adults With Type 2 DiabetesCompletedNCT03207893Not applicable
• Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle ModificationCompletedNCT03196895Not applicable
• Lifestyle Modification for Type 2 Diabetes Involving Reduction of After-meal Blood Glucose ElevationsCompletedNCT02432391Not applicable
• Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney DiseaseTerminatedNCT01101269Not applicable
• Lifestyle Intervention's Impact on Health Care CostsCompletedNCT00717158Not applicable